RedHill teams with Mayo Clinic, MD Anderson on new cancer trial
Tel-Aviv, Israel-based RedHill Biopharma (Nasdaq: RDHL) – which is continuing to build up its U.S. commercial operations based in Raleigh – is teaming with the Mayo Clinic and The University of Texas MD Anderson Cancer Center on a new cancer trial.
The new Phase IIa study is for YELIVA – a product candidate RedHill acquired from Apogee Biotechnolo gy back in 2015 – for the treatment of cholangiocarcinoma, or bile duct cancer.
It will enroll patients at Mayo Clinic campuses in both Arizona… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 28, 2017 Category: Pharmaceuticals Authors: Jennifer Henderson Source Type: news
Sirnaomics' Leading siRNA Therapeutic Candidate, STP705, Granted Orphan Designation for Treatment of Cholangiocarcinoma
GAITHERSBURG, Md., Dec. 6, 2017 -- (Healthcare Sales & Marketing Network) -- Sirnaomics, Inc. (www.sirnaomics.com), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that the Office of Orphan Product De... Biopharmaceuticals, Oncology, FDA Sirnaomics, Cholangiocarcinoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 6, 2017 Category: Pharmaceuticals Source Type: news
PCI Biotech starts dosing in Phase I extension study for bile duct cancer
Norwegian biopharmaceutical firm PCI Biotech has started dosing patients in a Phase I extension study with fimaCHEM to treat inoperable perihilar bile duct cancer. (Source: Drug Development Technology)
Source: Drug Development Technology - August 14, 2017 Category: Pharmaceuticals Source Type: news
Raw fish dishes in Thailand are full of deadly parasites
One of the major causes of bile duct cancer, which kills 20,000 Thais each year, is a parasitic flatworm native to the Mekong region and found in freshwater fish. (Source: the Mail online | Health)
Source: the Mail online | Health - June 28, 2017 Category: Consumer Health News Source Type: news
Avoid raw fish dishes during your holiday in Thailand!
One of the major causes of bile duct cancer, which kills 20,000 Thais each year, is a parasitic flatworm native to the Mekong region and found in freshwater fish. (Source: the Mail online | Health)
Source: the Mail online | Health - June 28, 2017 Category: Consumer Health News Source Type: news
How bile duct cancer develops and how it can be prevented
(German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)) What promotes the development of bile duct cancer in the liver? Are these factors different from those that are responsible for the much more common hepatocellular carcinomas? Scientists from the Heidelberg and Munich have been the first to uncover the molecular causes that selectively lead to the development of bile duct cancer in mice. The researchers also discovered that antioxidants or an inhibitor of a specific key enzyme can be used to stop this cancer-promoting process. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 12, 2017 Category: Cancer & Oncology Source Type: news
FISH Beneficial for Diagnosing Cholangiocarcinoma
FISH increased sensitivity of brush cytology for cholangiocarcinoma while preserving specificity (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 9, 2017 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Pathology, Journal, Source Type: news
Chemo Drug May Buy Time for Those With Bile Duct Cancer
Title: Chemo Drug May Buy Time for Those With Bile Duct CancerCategory: Health NewsCreated: 5/18/2017 12:00:00 AMLast Editorial Review: 5/19/2017 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 19, 2017 Category: Cancer & Oncology Source Type: news
Chemo Drug May Buy Time for Those With Bile Duct Cancer
For patients with the rare disease, survival benefit was seen in those given Xeloda, researchers say (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 18, 2017 Category: Cancer & Oncology Tags: Family Medicine, Gastroenterology, Nursing, Oncology, News, Source Type: news
Chemo Drug May Buy Time for Those with Bile Duct Cancer
For patients with the rare disease, survival benefit was seen in those given Xeloda, researchers say Source: HealthDay Related MedlinePlus Pages: Bile Duct Cancer, Cancer Chemotherapy (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - May 18, 2017 Category: Consumer Health News Source Type: news
Chemo Drug, Xeloda, May Buy Time for Those With Bile Duct Cancer
THURSDAY, May 18, 2017 -- The chemotherapy drug Xeloda may prolong survival in those struck by a type of digestive system cancer, a new study finds.
People with bile duct cancer who received the medication lived for an average of about 17 months... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 18, 2017 Category: General Medicine Source Type: news
Chemo Drug May Buy Time for Those With Bile Duct Cancer
THURSDAY, May 18, 2017 -- The chemotherapy drug Xeloda may prolong survival in those struck by a type of digestive system cancer, a new study finds.
People with bile duct cancer who received the medication lived for an average of about 17 months... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 18, 2017 Category: General Medicine Source Type: news
Chemo Drug May Buy Time for Those With Bile Duct Cancer
For patients with the rare disease, survival benefit was seen in those given Xeloda, researchers say (Source: Cancercompass News: Colorectal Cancer)
Source: Cancercompass News: Colorectal Cancer - May 18, 2017 Category: Cancer & Oncology Source Type: news
Capecitabine improves post-surgery survival period in bile duct cancer patients
A Cancer Research UK-funded trial (BILCAP) showed that the chemotherapy drug capecitabine increased the survival period of bile duct cancer patients by up to one and a half years after undergoing surgery for the disease. (Source: Drug Development Technology)
Source: Drug Development Technology - May 17, 2017 Category: Pharmaceuticals Source Type: news
Drug improves survival of patients with rare cancer by almost a quarter
(Cancer Research UK) Patients who take capecitabine after surgery for bile duct cancer live for almost a year and a half longer than those not given the drug. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 17, 2017 Category: Cancer & Oncology Source Type: news
